Underlying Mechanisms of Helicobacter pylori in Caries Progression and the Corresponding Dual-Responsive Hydrogel-Based Intervention
Related Experiment Video
Updated: Nov 3, 2026

Development of Amelogenin-chitosan Hydrogel for In Vitro Enamel Regrowth with a Dense Interface
Published on: July 10, 2014
Zixun Lan1,2, Xiang Shen3, Tingting Zhong3
1Jiangxi Provincial Engineering Center for Digital and Intelligent Industrial Technology of Maxillofacial Rehabilitation, Department of Stomatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Abstract:
Helicobacter pylori (H. pylori) infects nearly half of the global population. Given that H. pylori is considered poorly adapted to the oral environment, previous studies have mainly focused on gastric infection. By contrast, how H. pylori persists in the oral cavity and relates to oral diseases remains unclear. This study investigates the role of H. pylori in caries progression. The results show that H. pylori is retained within Streptococcus mutans (S. mutans) biofilms, and its presence is associated with transcriptional remodeling in S. mutans, alongside increased overall cariogenic potential of the mixed biofilm. In a rat caries model, H. pylori co-colonization aggravates caries progression and oral microbiota dysbiosis. To address this pathological niche, a multifunctional hydrogel, termed GPAM, is designed by integrating a Cu2O@Pt heterojunction (MCP) with amorphous calcium phosphate (ACP). Under activation by yellow light and ultrasound, MCP generates reactive oxygen species (ROS) to disrupt S. mutans-H. pylori mixed biofilms. Meanwhile, released Cu2+ reduces H. pylori urease activity, and ACP promotes tooth remineralization. GPAM also shows microbiota-modulating potential. Together, these findings provide insight into H. pylori-associated caries progression and support GPAM as a multifunctional therapeutic strategy for mixed biofilms and caries-related damage.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...